|ACUR -- USA Stock|| |
USD 0.13 0.0246 15.91%
Dr. Albert W. Brzeczko Ph.D. serves as an Vice President, Technical Affairs of Acura Pharmaceutical Technologies, Inc. since February 2009. From 1999 through 2009, Dr. Brzeczko was Vice President, Global Pharma New Product Development and Pharma Technologies for International Specialty Products, Inc., a contract services group specializing in the development of technologies for the bioenhancement of poorly soluble drugs. Prior to 1999, Dr. Brzeczko held various positions of increasing responsibility in pharmaceutical product development with UPM Pharmaceuticals, Banner Pharmacaps, Mylan Laboratories, and DuPont Merck
Age: 59 VP Since 2009 Ph.D
Brzeczko received a BS degree in biochemistry and a Ph.D. in pharmaceutical sciences from the University of Maryland.